Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIBRella: ella® Use in Simulated OTC Environment
NCT03208985Phase 3Completed
- Sponsor
- HRA Pharma
- Start
- May 2017
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ulipristal in unintended pregnancy, sponsored by HRA Pharma. Started May 2017; status: completed.
02
Drugs
ulipristal
03
Conditions
unintended pregnancy
Beyond the preview
Go deeper on NCT03208985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03208985.